发布时间
2026/03/25 04:5812 分钟前源站更新
2026/03/25 04:5812 分钟前首次抓取
2026/03/25 04:5812 分钟前发布时间
12 分钟前源站更新
12 分钟前首次抓取
12 分钟前用于追踪这条内容的来源与记录标识。
Source
原始链接
发布时间
2026/03/25 04:5812 分钟前源站更新
2026/03/25 04:5812 分钟前首次抓取
2026/03/25 04:5812 分钟前发布时间
12 分钟前源站更新
12 分钟前首次抓取
12 分钟前用于追踪这条内容的来源与记录标识。
Source
原始链接
Trump's psychedelic drug order boosts investor interest with promise of faster reviews
发布时间
143 天前
2026-05-18 10:10:22 UTC
源站更新
143 天前
2026-05-18 10:12:42 UTC
首次抓取
143 天前
2026-05-18 13:25:51 UTC
特朗普签署行政命令加速迷幻药物研发，提升了投资者对该领域的兴趣并有望缩短监管审查周期，但研究人员提醒新疗法上市仍需时日。
President Trump's executive order to accelerate psychedelic drug development has sparked investor interest and hopes for faster FDA and DEA coordination, though researchers warn that most treatments remain in early stages and face significant regulatory and funding hurdles.
用于追踪这条内容的来源与记录标识。
